Bilastine Ingen Pharma

Medicinal product

(Invented) name

Bilastine Ingen Pharma

Active substance (s)

Bilastinas

Strength

20 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis/Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R06AX29, Bilastine

Marketing authorisation holder

SIA Ingen Pharma, Latvija

Date of authorisation

2025-11-28

Date of renewal

Documents

5915 Bilastine IP_Rp.docx

5915 Bilastine IP_Nerp.docx

5915 pakuotes lapelis_2025-11-28_Rp.docx

5915 pakuotes lapelis_2025-11-28_Nerp.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Bilastinas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119255	105359	1105359	lizdinė plokštelė	N10		Nereceptinis	LT/1/25/5915/001	Netiekiama	-	-	No	-	-
119256	105360	1105360	lizdinė plokštelė	N20		Receptinis	LT/1/25/5915/002	Netiekiama	-	-	No	-	-
119257	105361	1105361	lizdinė plokštelė	N30		Receptinis	LT/1/25/5915/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-11-28	Registruotas